AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.
Saved in:
| Title: | AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. |
|---|---|
| Authors: | Knutson TP; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Luo B; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Kobilka A; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Lyman J; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN, USA., Guo S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Munro SA; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA., Li Y; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Heer R; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear, UK.; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Gaughan L; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK., Morris MJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Ryan CJ; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Antonarakis ES; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Armstrong AJ; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Dehm SM; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Urology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu. |
| Source: | Nature communications [Nat Commun] 2024 Dec 11; Vol. 15 (1), pp. 10648. Date of Electronic Publication: 2024 Dec 11. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39663356 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Knutson+TP%22">Knutson TP</searchLink>; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Luo+B%22">Luo B</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Kobilka+A%22">Kobilka A</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Lyman+J%22">Lyman J</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Graduate Program in Molecular, Cellular, and Developmental Biology and Genetics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Guo+S%22">Guo S</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Munro+SA%22">Munro SA</searchLink>; Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Heer+R%22">Heer R</searchLink>; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, Tyne and Wear, UK.; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK.<br /><searchLink fieldCode="AU" term="%22Gaughan+L%22">Gaughan L</searchLink>; Translational and Clinical Research Institute, NU Cancer, Newcastle upon Tyne, Tyne and Wear, UK.<br /><searchLink fieldCode="AU" term="%22Morris+MJ%22">Morris MJ</searchLink>; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ryan+CJ%22">Ryan CJ</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Antonarakis+ES%22">Antonarakis ES</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+AJ%22">Armstrong AJ</searchLink>; Department of Medicine, Division of Medical Oncology, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Halabi+S%22">Halabi S</searchLink>; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Dehm+SM%22">Dehm SM</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu.; Department of Urology, University of Minnesota, Minneapolis, MN, USA. dehm@umn.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Dec 11; Vol. 15 (1), pp. 10648. <i>Date of Electronic Publication: </i>2024 Dec 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39663356 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-024-54847-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 10648 Titles: – TitleFull: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Knutson TP – PersonEntity: Name: NameFull: Luo B – PersonEntity: Name: NameFull: Kobilka A – PersonEntity: Name: NameFull: Lyman J – PersonEntity: Name: NameFull: Guo S – PersonEntity: Name: NameFull: Munro SA – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Heer R – PersonEntity: Name: NameFull: Gaughan L – PersonEntity: Name: NameFull: Morris MJ – PersonEntity: Name: NameFull: Beltran H – PersonEntity: Name: NameFull: Ryan CJ – PersonEntity: Name: NameFull: Antonarakis ES – PersonEntity: Name: NameFull: Armstrong AJ – PersonEntity: Name: NameFull: Halabi S – PersonEntity: Name: NameFull: Dehm SM IsPartOfRelationships: – BibEntity: Dates: – D: 11 M: 12 Text: 2024 Dec 11 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |